Bio-rad Laboratories, Inc. Technicals
Bio-rad Laboratories, Inc. logo

Bio-rad Laboratories, Inc.(ALLUS_BIO)

$361.030.43%

Market is closed - opens 7 PM, 12 Jun 2023

Insights

  • Bio-rad Laboratories, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Bio-rad Laboratories, Inc. stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Bio-rad Laboratories, Inc. stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Bio-rad Laboratories, Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
38.1
Neutral
Stochastic
19.9, 17.16
Buy
Ultimate Oscillator
43.24
Neutral
Stochastic Relative Strength Index
61.48, 77.51
Neutral
Moving Average Convergence Divergence
-16.18, -18.42
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
377.44
Buy
20
376.73
Sell
50
429.69
Sell

Exponential Moving Average

Period (Days)

Value

Action

10
377.16
Sell
20
387.87
Sell
50
416.22
Sell

Volume Weighted Moving Average

Period (Days)

Value

Action

10
377.16
Neutral
20
377.37
Neutral
50
410.94
Sell

Double Exponential Moving Average

Period (Days)

Value

Action

10
370.19
Buy
20
364.77
Sell
50
386.05
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
373.67
Buy
20
365.3
Buy
50
363.76
Sell

Pivot

Pivot

Value

Resistance L3
382.06
Resistance L2
379.2
Resistance L1
375.78
Pivot Point
372.93
Support L1
369.51
Support L2
366.65
Support L3
363.23

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.